Axelyf

Örn Almarsson

Chief Executive Officer and Co-founder
Axelyf
  • Axelyf is a team spanning the US, UK and Iceland – experts with experience from Moderna and top biotech/pharma developing next-generation lipid nanoparticle delivery systems
  • Lead investigational candidate AXL-003 is in early development for autoimmune disease
  • Technology combines a potent new ionizable lipid library, novel surface chemistry and AI-informed design by a proprietary machine learning model